Cingulate CING
NASDAQ CING
$4.66 +0.13 (+2.87%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cingulate (CING) Revenue (2024 - 2026)

Updated

Analysis

Cingulate (CING) Revenue (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 Cingulate 61.34 Mn 6.35 Mn - -141,276.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -141,276.00
Jun 30, 2025 -138,761.00
Mar 31, 2025 -96,784.00
Jun 30, 2024 -3,497.00
Mar 31, 2024 -24,260.00
API Access

Cingulate Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CING&period=max&api_key=YOUR_API_KEY